A Distinctive Insight into Inorganic Sonosensitizers: Design Principles and Application Domains
W Qin, Q Yang, C Zhu, R Jiao, X Lin, C Fang, J Guo… - Small, 2024 - Wiley Online Library
Sonodynamic therapy (SDT) as a promising non‐invasive anti‐tumor means features the
preferable penetration depth, which nevertheless, usually can't work without …
preferable penetration depth, which nevertheless, usually can't work without …
Enhancing cancer chemo‐immunotherapy: innovative approaches for overcoming immunosuppression by functional nanomaterials
Chemotherapy is a critical modality in cancer therapy to combat malignant cell proliferation
by directly attacking cancer cells and inducing immunogenic cell death, serving as a vital …
by directly attacking cancer cells and inducing immunogenic cell death, serving as a vital …
Mitochondrial Localized In Situ Self‐Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer Therapy
Z Wang, Q Wang, H Cao, Z Wang, D Wang… - Advanced …, 2024 - Wiley Online Library
The inherent immune and metabolic tumor microenvironment (TME) of most solid tumors
adversely affect the antitumor efficacy of various treatments, which is an urgent issue to be …
adversely affect the antitumor efficacy of various treatments, which is an urgent issue to be …
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
L Zhou, Y Chen, D Xie, K Li, X Cui, CF Dietrich… - …, 2024 - Wiley Online Library
Nanomedicine‐assisted sonodynamic therapy (SDT) has emerged as one of the most
promising cancer therapies due to its unique advantages of high penetration, non‐radiation …
promising cancer therapies due to its unique advantages of high penetration, non‐radiation …
Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma
S Zhuo, C Tang, L Yang, Z Chen, T Chen… - Annals of …, 2023 - Taylor & Francis
Background Adult glioma progresses rapidly and has a poor clinical outcome. The focal
adhesion protein Kindlin-3 (encoded by the FERMT3 gene) participates in tumor …
adhesion protein Kindlin-3 (encoded by the FERMT3 gene) participates in tumor …
Nanoplatform‐based in vivo gene delivery systems for cancer therapy
R Luo, H Le, Q Wu, C Gong - Small, 2024 - Wiley Online Library
Gene therapy uses modern molecular biology methods to repair disease‐causing genes. As
a burgeoning therapeutic, it has been widely applied for cancer therapy. Since 1989, there …
a burgeoning therapeutic, it has been widely applied for cancer therapy. Since 1989, there …
Petaloid Metal–Organic Frameworks for Resiquimod Delivery To Potentiate Antitumor Immunity
C Zhang, Z Deng, X Sun, K Yuan, J Wang… - … Applied Materials & …, 2024 - ACS Publications
The morphological features of materials significantly influence their interactions with cells,
consequently affecting the cellular uptake of these materials. In this study, we examine the …
consequently affecting the cellular uptake of these materials. In this study, we examine the …
Quintuple Free‐Radical Therapy: An Ultralong‐Retention FAND for NIR‐Involved Multiple Site‐Acting Hypoxic Tumor Therapy
C Zhang, D Zhao, F Fang, L Zhu, W Li… - Advanced Functional …, 2024 - Wiley Online Library
The heavy dependence on intratumoral O2 and H2O2 availability has greatly restricted ROS‐
based therapy. Although O2/H2O2‐irrelevant free‐radical nanogenerator has garnered …
based therapy. Although O2/H2O2‐irrelevant free‐radical nanogenerator has garnered …
Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell Death
F Du, H Zhao, Y Song, Z Feng, K Liu… - Advanced Functional …, 2024 - Wiley Online Library
The vigorous development of cancer nanomedicine has revolutionized traditional oncology
medicine, but it is also limited by the continuous mutation of cunning cancer cells, leading to …
medicine, but it is also limited by the continuous mutation of cunning cancer cells, leading to …
Hydrogel Activation of Mincle Receptors for Tumor Cell Processing: A Novel Approach in Cancer Immunotherapy
J Lin, Y Zhou, C Li, B Li, H Hao, F Tian, H Li, Z Liu… - Biomaterials, 2024 - Elsevier
An obstacle in current tumor immunotherapies lies in the challenge of achieving sustained
and tumor-targeting T cell immunity, impeded by the limited antigen processing and cross …
and tumor-targeting T cell immunity, impeded by the limited antigen processing and cross …